CMS Asked To Weigh Coverage Of Trials For Surgical Diabetes Option
This article was originally published in The Gray Sheet
Executive Summary
Public commenters want CMS to provide reimbursement for clinical trials that would help determine whether weight-loss surgery is a reasonable and necessary treatment for type-2 diabetes in Medicare patients with a body mass index (BMI) below 35